Suppr超能文献

消极治疗体验对持续拒绝抗精神病药物的影响。

The impact of negative treatment experiences on persistent refusal of antipsychotics.

机构信息

Clinical Psychology and Psychotherapy, Institute of Psychology, Universität Hamburg.

Clinical Psychology and Psychotherapy, Philipps-Universität Marburg.

出版信息

Compr Psychiatry. 2016 Oct;70:165-73. doi: 10.1016/j.comppsych.2016.07.009. Epub 2016 Jul 30.

Abstract

AIMS

We investigate reasons for persistent medication refusal in schizophrenia spectrum disorders and test whether factors that speak for a rational decision, such as negative experiences with medication or low symptom distress predict medication refusal, even after taking differences in insight into account.

METHOD

We included 45 participants with schizophrenia spectrum disorders, of which 20 had refused antipsychotic medication for at least three months and assessed reasons for taking or not taking medication, labeling condition as mental disorder ("insight"), experiences with the previous treatments, symptoms and symptom distress, positive and negative consequences and experiences of psychosis, causal beliefs, therapeutic relationships with previous clinicians and attitudes towards medication.

RESULTS

Groups did not differ in symptom severity but medication refusers reported significantly less insight, less satisfaction with their most-recent psychiatrist and with previous medication, and more negative beliefs about harmful effects of medication. They also felt less informed about medication. After controlling for insight, the perceived helpfulness of the previous treating psychiatrist (OR=0.30, z=5.58, p=0.018) and of previous medication (OR=0.27, z=6.87, p=0.009) and feeling insufficiently informed about medication (OR=0.53, z=3. 85, p=0.050) significantly predicted medication discontinuation.

CONCLUSIONS

Building rapport with patients with a different view of the nature of their condition and encouraging informed decisions on medication are likely to improve medication adherence. However, the findings also suggest that refusing medication after a phase of initial adherence is also the consequence of negative experiences with medication and could result from weighing the pros against the cons.

摘要

目的

我们调查精神分裂症谱系障碍患者持续拒绝药物治疗的原因,并检验是否有支持理性决策的因素(如药物治疗的负面经历或低症状困扰)可以预测药物拒绝,即使考虑到洞察力的差异。

方法

我们纳入了 45 名精神分裂症谱系障碍患者,其中 20 名至少三个月拒绝抗精神病药物治疗,并评估了他们服药或不服药的原因,将精神障碍(“洞察力”)、之前治疗的经验、症状和症状困扰、积极和消极的后果以及精神病体验、因果信念、与之前临床医生的治疗关系以及对药物的态度作为标签条件。

结果

两组在症状严重程度上没有差异,但药物拒绝者报告的洞察力明显较少,对最近的精神科医生和之前的药物治疗的满意度较低,对药物的有害影响的负面信念更多。他们也觉得对药物的了解较少。在控制了洞察力之后,之前治疗的精神科医生(OR=0.30,z=5.58,p=0.018)和之前药物治疗(OR=0.27,z=6.87,p=0.009)的有效性以及对药物了解不足(OR=0.53,z=3.85,p=0.050)显著预测了药物停药。

结论

与对自身状况性质有不同看法的患者建立融洽关系,并鼓励对药物治疗做出知情决策,可能会提高药物的依从性。然而,这些发现也表明,在初始依从阶段后拒绝药物治疗也是药物治疗负面经历的结果,并且可能是权衡利弊的结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验